Browse > Article

Preparation and Evaluation of Adhesive Hydrogel of Ketoprofen Using Microsphere System  

Cho, Young-Ho (Department of Pharmaceutical Engineering, Konyang University)
Lee, Gye-Won (Department of Pharmaceutical Engineering, Konyang University)
Publication Information
KSBB Journal / v.25, no.3, 2010 , pp. 297-302 More about this Journal
Abstract
Ketoprofen is one of the propionic acid class of nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. The most common side effects from ketoprofen after oral administration are gastrointestinal irritation, diarrhea, abdominal pain and retention of fluid. Ketoprofen was formulated as water-soluble gels to reduce these side effects. To increase the skin permeability of ketoprofen, microsphere containing ketoprofen was prepared with chitosan and ploy-$\varepsilon$-caprolactone. And then prepared microsphere was manufactured as an adhesive hydrogel with polyvinylpyrrolidone K-25, polyethylene glycol 4000, and various permeation enhancers. The flux and permeability of ketoprofen were evaluated. As the concentration of tween 80 and enhancers increased, the flux of ketroprofen was accelerated. Also the permeation rate was facilitated by enhancers, but did not affect the lag time. From these results, the adhesive hydrogel using microsphere could be a good delivery system for ketoprofen to improve the skin permeation.
Keywords
ketoprofen; microsphere; polyvinylpyrrollidone K-25; enhancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Aungst, B. J., N. J. Rogers, and E. Shefter (1986) Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 33: 225-234.   DOI
2 Small, D. M. (1984) Lateral chain packing in lipids and membranes J. Lipid Res. 25: 1490-1500.
3 Ishizaki, T., T. Sasaki, T. Suganima, Y. Horai, K. Chiba, M. Watanabe, W. Asuke, and H. Hosh (1980) Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration. Eur. J. Clin. Pharmacol. 18: 407-414.   DOI   ScienceOn
4 Golden, G. M., J. E. Mckie, and R. O. Porrs (1987) Role of stratum corneum lipid fluidity in transdermal drug flux. J. Pharm. Sci. 76: 25-28.   DOI
5 Saita, M., H. Takenoshita, Y. Taniguchi, K. Fruta, T. Aoki, Y. Shimozono, A. Toda, T. Mizoquchi, A. Nakagawa, K. Matsuura, and M. Tsuji (1985) Pharmacological studies of ketoprofen gel-type ointment (KPG)(1), Anti-inflammatory and analgesic activities of KPG by topical application. Oyo Yakuri 20: 833-843.
6 Green, P. G., R. H. Guy, and J. Hadgraft (1988) In vitro and in vivo enhancement of skin permeation with oleic and lauric acids. Int. J. Pharm. 48: 103-111.   DOI
7 Barry, B. W. (1987) Mode of action of penetration enhancers in human skin. J. Control. Release. 6: 85-97.   DOI   ScienceOn
8 Naik, A., L. A. R. M. Pechtold, R. O. Potts, and R. H. Guy (1995) Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J. Control. Release. 37: 299-306.   DOI   ScienceOn
9 Fujimura, H., V. Hiramatsu, Y. Tamura, K. Maekawa, and H. Yokota (1985) Pharmacological studies of ketoprofen ointment. Yakuri to Chiryo 13: 4115-4127.
10 Kyuki, K., K. Tsurumi, and H. Fujimura (1985) Antiinflammatory activity of ketoprofen cream in topical application. Oyo Yakuri, 29: 969-976.
11 Williams, A. C. and B. Barry (1990) Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm. Res. 8: 17-24.
12 Julou, L., J. C. Guyonnet, R. Ducrot, J. Fournel, and J. Pasquet (1976) Ketoprofen; Main pharmacological properties - Outline of toxicological and pharmacokinetic data. Scan. J. Rheumatol. Suppl. 14: 33-44.
13 Kanto, T. G. (1986) Ketoprofen; A review of its pharmacological and clinical properties. Pharmacother. 6: 93-103.   DOI
14 Debruyne, D., B. H. de Ligny, J. Ryckelynck, F. Albessard, and M. Moulin (1987) Clinical Pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion. Clin. Pharmacokinet. 12: 214-221.   DOI   ScienceOn
15 Upton, R. A., J. N. Buskin, R. L. Williams, N. H. G. Holfod, and S. Riegelman (1980) Negligible excretion of unchanged Ketoprofen, naproxen or probenecid in urine. J. Pharm. Sci. 69: 1254-1257.   DOI
16 Harris, R. H. and I. Vavra (1985) Ketoprofen. In Rainsford, K. D. (Ed.), "Anti-Inflammatory and Anti-rheumatic Drugs". Vol. II, pp. 151-169. CRC Press, NY, USA.